• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测育龄期三阴性乳腺癌患者生存的列线图的构建与验证

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.

作者信息

Cui Xiang, Song Deba, Li Xiaoxu

机构信息

Department of Thyroid and Breast Surgery, The First People's Hospital of Shangqiu, Shangqiu, China.

出版信息

Front Oncol. 2021 Feb 8;10:636549. doi: 10.3389/fonc.2020.636549. eCollection 2020.

DOI:10.3389/fonc.2020.636549
PMID:33628740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7898905/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer with poorest clinical outcomes. Patients of childbearing age have a higher probability of TNBC diagnosis, with more demands on maintenance and restoration of physical and psychosocial function. This study aimed to design effective and comprehensive nomograms to predict survival in these patients.

METHODS

We used the SEER database to identify patients with TNBC aged between 18 and 45 and randomly classified these patients into a training (n=2,296) and a validation (n=2,297) cohort. Nomograms for estimating overall survival (OS) and breast cancer-specific survival (BCSS) were generated based on multivariate Cox proportional hazards models and competing-risk models in the training cohort. The performances of the nomograms were quantified in the validation cohort using calibration curves, time-dependent receiver operating characteristic (ROC) curves and Harrell's concordance index (C-index).

RESULTS

A total of 4,593 TNBC patients of childbearing age were enrolled. Four prognostic factors for OS and six for BCSS were identified and incorporated to construct nomograms. In the validation cohort, calibration curves showed excellent agreement between nomogram-predicted and actual survival data. The nomograms also achieved relatively high Harrell's C-indexes and areas under the time-dependent ROC curves for estimating OS and BCSS in both training and validation cohorts.

CONCLUSIONS

Independent prognostic factors were identified, and used to develop nomograms to predict OS and BCSS in childbearing-age patients with TNBC. These models could enable individualized risk estimation and risk-adapted treatment for these patients.

摘要

背景

三阴性乳腺癌(TNBC)是侵袭性最强的乳腺癌亚型之一,临床预后最差。育龄期患者TNBC诊断概率更高,对身体及心理社会功能的维持和恢复有更多需求。本研究旨在设计有效且全面的列线图以预测这些患者的生存情况。

方法

我们使用监测、流行病学和最终结果(SEER)数据库识别年龄在18至45岁之间的TNBC患者,并将这些患者随机分为训练队列(n = 2296)和验证队列(n = 2297)。基于训练队列中的多变量Cox比例风险模型和竞争风险模型生成了用于估计总生存期(OS)和乳腺癌特异性生存期(BCSS)的列线图。使用校准曲线、时间依赖性受试者工作特征(ROC)曲线和哈雷尔一致性指数(C指数)在验证队列中对列线图的性能进行量化。

结果

共纳入4593例育龄期TNBC患者。确定了4个OS预后因素和6个BCSS预后因素,并将其纳入以构建列线图。在验证队列中,校准曲线显示列线图预测的生存数据与实际生存数据之间具有良好的一致性。列线图在训练队列和验证队列中估计OS和BCSS时,还获得了相对较高的哈雷尔C指数和时间依赖性ROC曲线下面积。

结论

确定了独立的预后因素,并用于开发列线图以预测育龄期TNBC患者的OS和BCSS。这些模型能够为这些患者进行个体化风险评估和风险适应性治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/a174111cb25c/fonc-10-636549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/3ef7c57a8269/fonc-10-636549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/cdf29b38ffda/fonc-10-636549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/a174111cb25c/fonc-10-636549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/3ef7c57a8269/fonc-10-636549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/cdf29b38ffda/fonc-10-636549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7916/7898905/a174111cb25c/fonc-10-636549-g003.jpg

相似文献

1
Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.预测育龄期三阴性乳腺癌患者生存的列线图的构建与验证
Front Oncol. 2021 Feb 8;10:636549. doi: 10.3389/fonc.2020.636549. eCollection 2020.
2
Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.三阴性乳腺癌患者总生存和乳腺癌特异性生存预测列线图的开发与验证
Cancer Manag Res. 2018 Nov 19;10:5881-5894. doi: 10.2147/CMAR.S178859. eCollection 2018.
3
Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.列线图预测老年三阴性乳腺癌女性的生存率:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Technol Health Care. 2024;32(4):2445-2461. doi: 10.3233/THC-231240.
4
Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort.三阴性乳腺癌生存预测:基于人群的研究,使用监测、流行病学和最终结果(SEER)数据库及外部验证队列
Front Oncol. 2024 Jun 10;14:1388869. doi: 10.3389/fonc.2024.1388869. eCollection 2024.
5
Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.预测初诊转移性三阴性乳腺癌患者生存的列线图的建立和验证。
Sci Rep. 2022 Aug 29;12(1):14659. doi: 10.1038/s41598-022-18727-2.
6
Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort.育龄期转移性乳腺癌患者预后列线图的构建与验证:一项基于监测、流行病学和最终结果(SEER)数据库及中国队列的研究
Front Oncol. 2022 Nov 25;12:999873. doi: 10.3389/fonc.2022.999873. eCollection 2022.
7
Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.用于评估腔面型乳腺癌患者长期总生存率和乳腺癌特异性生存率的列线图。
Oncotarget. 2016 Apr 12;7(15):20496-506. doi: 10.18632/oncotarget.7975.
8
Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.基于 SEER 的人群研究:列线图预测乳腺癌脑转移的生存。
World Neurosurg. 2019 Aug;128:e823-e834. doi: 10.1016/j.wneu.2019.04.262. Epub 2019 May 13.
9
Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.横结肠癌死亡概率的预测:基于21469例患者的竞争风险列线图
J Cancer Res Clin Oncol. 2023 Sep;149(12):10435-10452. doi: 10.1007/s00432-023-04913-w. Epub 2023 Jun 6.
10
Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.预测乳腺癌所有四种亚型生存率的列线图:一项基于监测、流行病学和最终结果(SEER)的人群研究。
Ann Transl Med. 2020 Apr;8(8):544. doi: 10.21037/atm-20-2808.

引用本文的文献

1
Outperforming Traditional Staging: A Novel Nomogram for HR-Positive Breast Cancer.超越传统分期:一种用于激素受体阳性乳腺癌的新型列线图
Ther Clin Risk Manag. 2025 Feb 25;21:191-208. doi: 10.2147/TCRM.S485685. eCollection 2025.
2
A nomogram for predicting overall survival of breast cancer with regional lymph node metastasis in young women.预测年轻女性伴有区域淋巴结转移的乳腺癌总生存期的列线图。
Transl Cancer Res. 2024 Feb 29;13(2):542-557. doi: 10.21037/tcr-23-1825. Epub 2024 Feb 22.
3
Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort.

本文引用的文献

1
A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.用于预测新发转移性乳腺癌患者生存的列线图:一项基于人群的研究。
BMC Cancer. 2020 Oct 12;20(1):982. doi: 10.1186/s12885-020-07449-1.
2
Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.预测老年乳腺癌女性乳腺癌特异性死亡率的列线图
Med Sci Monit. 2020 Sep 13;26:e925210. doi: 10.12659/MSM.925210.
3
Nomograms for prediction of overall and cancer-specific survival in young breast cancer.
育龄期转移性乳腺癌患者预后列线图的构建与验证:一项基于监测、流行病学和最终结果(SEER)数据库及中国队列的研究
Front Oncol. 2022 Nov 25;12:999873. doi: 10.3389/fonc.2022.999873. eCollection 2022.
预测年轻乳腺癌患者总生存和癌症特异性生存的列线图。
Breast Cancer Res Treat. 2020 Nov;184(2):597-613. doi: 10.1007/s10549-020-05870-5. Epub 2020 Sep 4.
4
Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.预测乳腺癌所有四种亚型生存率的列线图:一项基于监测、流行病学和最终结果(SEER)的人群研究。
Ann Transl Med. 2020 Apr;8(8):544. doi: 10.21037/atm-20-2808.
5
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.对年轻和老年三阴性乳腺癌患者进行综合分子谱分析表明存在不同的生物学基础和临床管理策略。
Cancer. 2020 Jul 15;126(14):3209-3218. doi: 10.1002/cncr.32922. Epub 2020 May 8.
6
Novel prognostic nomograms for female patients with breast cancer and bone metastasis at presentation.初诊时乳腺癌伴骨转移女性患者的新型预后列线图。
Ann Transl Med. 2020 Mar;8(5):197. doi: 10.21037/atm.2020.01.37.
7
Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.乳腺癌肿瘤组织病理学、发病时的分期和极端年龄的治疗。
Breast Cancer Res Treat. 2020 Feb;180(1):227-235. doi: 10.1007/s10549-020-05542-4. Epub 2020 Jan 24.
8
A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.一种用于预测浸润性微乳头型乳腺癌生存结局的竞争列线图。
J Cancer. 2019 Nov 1;10(27):6801-6812. doi: 10.7150/jca.27955. eCollection 2019.
9
Prognostic Values Of Preoperative Serum CEA And CA125 Levels And Nomograms For Young Breast Cancer Patients.年轻乳腺癌患者术前血清CEA和CA125水平的预后价值及列线图
Onco Targets Ther. 2019 Oct 24;12:8789-8800. doi: 10.2147/OTT.S221335. eCollection 2019.
10
Breast cancer statistics, 2019.乳腺癌统计数据,2019 年。
CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.